Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
UBS
Deloitte
McKinsey
Daiichi Sankyo
Baxter
Chinese Patent Office
Fuji
Express Scripts

Generated: April 23, 2018

DrugPatentWatch Database Preview

Scherer Rp Company Profile

« Back to Dashboard

What is the competitive landscape for SCHERER RP, and what generic and branded alternatives to SCHERER RP drugs are available?

SCHERER RP has four approved drugs.



Summary for Scherer Rp
US Patents:0
Tradenames:4
Ingredients:3
NDAs:4

Drugs and US Patents for Scherer Rp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scherer Rp THEOPHYLLINE-SR theophylline CAPSULE, EXTENDED RELEASE;ORAL 088255-001 Jun 12, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Scherer Rp THEOPHYLLINE theophylline CAPSULE;ORAL 084731-003 Nov 7, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Scherer Rp VALPROIC ACID valproic acid CAPSULE;ORAL 070195-001 Jul 2, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Scherer Rp DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride CAPSULE;ORAL 086440-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Express Scripts
Fish and Richardson
Healthtrust
Cantor Fitzgerald
US Department of Justice
Cipla
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.